Mind Medicine Australia FREE Webinar - Mindfulness, Compassion & Psychedelic-Assisted Psychotherapy with Dr Ronald D. Siegel
Event description
Don’t miss out - Get your tickets early!
Join this FREE WEBINAR presented by Dr Ronald D. Siegel (USA).
TOPIC: Mindfulness, Compassion, & Psychedelic-Assisted Psychotherapy: Harnessing the Synergies
How might contemplative practices prepare us to use psychedelic medicines? How might they help us guide others? Can we use meditative practices during the sessions themselves? Might they help us integrate what arises in sessions afterwards? And how can psychedelics support our contemplative practice?
Refined over thousands of years in countless wisdom traditions, mindfulness and compassion practices can help us accept and integrate difficult mental contents and parts of ourselves, deconstruct our conventional sense of self, and connect us more deeply to others and the wider world—making them a powerful complement to psychedelic exploration.
Our Webinar Will Explore:
1. The varieties of contemplative practice that can augment psychedelics for psychological and spiritual growth and healing
2. How mindfulness and self-compassion practice can prepare us for psychedelic journeys
3. The skills we need to effectively guide psychedelic sessions and how contemplative practices can cultivate them
4. How meditative practices can support us during psychedelic sessions and make them more fruitful
5. The use of mindfulness and self-compassion practices to integrate insights from psychedelic journeys
6. How psychedelics can kindle transpersonal experiences, making them more accessible in meditation practice
7. The dangers of spiritual bypass in psychedelic work
EVENT DETAILS
- DATE: 17th April 2024
- TIME: 11:55am (AEST) for 12:00pm start, finishing at 1:15pm
- DURATION: 75 minutes (incl Q&A)
- LOCATION: Online - a link will be emailed to you with the viewing details
ABOUT THE PRESENTER
Dr Ronald D. Siegel (USA)
Assistant Professor of Psychology, Harvard Medical School
Dr. Ronald D. Siegel is Assistant Professor of Psychology, part time, at Harvard Medical School and serves on the Board of Directors and faculty of the Institute for Meditation and Psychotherapy. He is the author or editor of many books, including The Extraordinary Gift of Being Ordinary: Finding Happiness Right Where You Are; The Mindfulness Solution: Everyday Practices for Everyday Problems, and Sitting Together: Essential Skills for Mindfulness-Based Psychotherapy. He is also a regular contributor to other professional publications, and is co-director of the annual Harvard Medical School Conferences on Meditation and Psychotherapy as well as Psychedelic-Assisted Psychotherapy. His exploration of psychedelic medicine began early in life and led him to become a long-time student of mindfulness meditation. He teaches internationally about the application of mindfulness practice in psychotherapy and other fields and the relationship between mindfulness practice and psychedelic medicine, while maintaining a private clinical practice in Lincoln, Massachusetts.
---
MEDICINAL PSYCHEDELIC TREATMENTS
Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.
The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.
SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT
Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.
DISCLAIMER
Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.